A Quantitative Structure–Activity Relationship Study of Calpeptin (Calpain Inhibitor) as an Anticancer Agent. Issue 5 (5th January 2018)

• Record Type: Journal Article
• Authors: Irandoost, Ali; Tahmasbpour, Eisa; Beigi Harchegani, Asghar; Borna, Hojat; Iman, Maryam
• Is Part Of: Journal of the Chinese Chemical Society. Volume 65:Issue 5(2018)
• Page Start: 567
• Page End: 577
• Publication Date: 2018-01-05
• Subjects: Anticancer -- Calpain -- Calpeptin -- Multiple linear regression -- Quantitative structure–activity relationship; Chemistry -- Periodicals; Electronic journals; 540.5
• DOI: 10.1002/jccs.201700322
• Languages: English
• ISSNs: 0009-4536

Abstract

Abstract : Calpeptin analogs show anticancer properties with inhibition of calpain. In this work, we applied a quantitative structure–activity relationship (QSAR) model on 34 calpeptin derivatives to select the most appropriate compound. QSAR was employed to generate the models and predict the more significant compounds through a series of calpeptin derivatives. The HyperChem, Gaussian 09, and Dragon software programs were used for geometry optimization of the molecules. The 2D and 3D molecular structures were drawn by ChemDraw (Ultra 16.0) and Chem3D (Pro16.0) software. The Unscrambler program was used for the analysis of data. Multiple linear regression (MLR‐MLR), partial least‐squares (MLR‐PLS1), principal component regression (MLR‐PCR), a genetic algorithm‐artificial neural networks (GA‐ANN), and a novel similarity analysis‐artificial neural network (SA‐ANN) method were used to create QSAR models. Among the three MLR models, MLR‐MLR provided better statistical parameters. The R 2 and RMSE of the prediction were estimated as 0.8248 and 0.26, respectively. Nevertheless, the constructed model using GA‐ANN revealed the best statistical parameters among the studied methods ( R 2 test = 0.9643, RMSE test = 0.0155, R 2 train = 0.9644, RMSE train = 0.0139). The GA‐ANN model is found to be the most favorable method among the statistical methods and can be employed for designing new calpeptin analogs as potent calpain inhibitors in cancer treatment. Abstract : GA‐ANN model is used for designing new calpeptin analog as a potent anticancer drug.